Conyn-van Spaendonck MA - Search Results

1

Sero-epidemiology of measles antibodies in the Netherlands, a cross-sectional study in a national sample and in communities with low vaccine coverage.

van den Hof S, Berbers GA, de Melker HE, Conyn-van Spaendonck MA. van den Hof S, et al. Vaccine. 1999 Dec 10;18(9-10):931-40. doi: 10.1016/s0264-410x(99)00348-5. Vaccine. 1999. PMID: 10580207

2

Protecting the vaccinating population in the face of a measles epidemic: assessing the impact of adjusted vaccination schedules.

van den Hof S, Wallinga J, Widdowson MA, Conyn-van Spaendonck MA. van den Hof S, et al. Epidemiol Infect. 2002 Feb;128(1):47-57. doi: 10.1017/s0950268801006409. Epidemiol Infect. 2002. PMID: 11895090 Free PMC article.

3

Evaluation of the national immunisation programme in the Netherlands: immunity to diphtheria, tetanus, poliomyelitis, measles, mumps, rubella and Haemophilus influenzae type b.

de Melker HE, van den Hof S, Berbers GA, Conyn-van Spaendonck MA. de Melker HE, et al. Vaccine. 2003 Jan 30;21(7-8):716-20. doi: 10.1016/s0264-410x(02)00587-x. Vaccine. 2003. PMID: 12531347

4

Options for improvement of the Dutch measles vaccination schedule.

van den Hof S, Wallinga J, Widdowson MA, Conyn-van Spaendonck MA. van den Hof S, et al. Vaccine. 2003 Jan 30;21(7-8):721-4. doi: 10.1016/s0264-410x(02)00588-1. Vaccine. 2003. PMID: 12531348

5

Measles epidemic in the Netherlands, 1999-2000.

van den Hof S, Conyn-van Spaendonck MA, van Steenbergen JE. van den Hof S, et al. J Infect Dis. 2002 Nov 15;186(10):1483-6. doi: 10.1086/344894. Epub 2002 Oct 29. J Infect Dis. 2002. PMID: 12404165

6

Prevalence of antibodies against rubella virus in The Netherlands 9 years after changing from selective to mass vaccination.

de Haas R, van den Hof S, Berbers GA, de Melker HE, Conyn-van Spaendonck MA. de Haas R, et al. Epidemiol Infect. 1999 Oct;123(2):263-70. doi: 10.1017/s0950268899002939. Epidemiol Infect. 1999. PMID: 10579446 Free PMC article.

7

Non-participation in a population-based seroprevalence study of vaccine-preventable diseases.

De Melker HE, Nagelkerde NJ, Conyn-van Spaendonck MA. De Melker HE, et al. Epidemiol Infect. 2000 Apr;124(2):255-62. doi: 10.1017/s0950268899003234. Epidemiol Infect. 2000. PMID: 10813151 Free PMC article.

8

The prevalence of antibodies to hepatitis A virus and its determinants in The Netherlands: a population-based survey.

Termorshuizen F, Dorigo-Zetsma JW, de Melker HE, van den Hof S, Conyn-Van Spaendonck MA. Termorshuizen F, et al. Epidemiol Infect. 2000 Jun;124(3):459-66. doi: 10.1017/s0950268899003842. Epidemiol Infect. 2000. PMID: 10982070 Free PMC article.

9

Immunity to poliomyelitis in The Netherlands.

Conyn-Van Spaendonck MA, de Melker HE, Abbink F, Elzinga-Gholizadea N, Kimman TG, van Loon T. Conyn-Van Spaendonck MA, et al. Am J Epidemiol. 2001 Feb 1;153(3):207-14. doi: 10.1093/aje/153.3.207. Am J Epidemiol. 2001. PMID: 11157405

10

Measles outbreak in a community with very low vaccine coverage, the Netherlands.

van den Hof S, Meffre CM, Conyn-van Spaendonck MA, Woonink F, de Melker HE, van Binnendijk RS. van den Hof S, et al. Emerg Infect Dis. 2001;7(3 Suppl):593-7. doi: 10.3201/eid0707.010743. Emerg Infect Dis. 2001. PMID: 11485681 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

60 results

Search Page

Filters